J&J Rebuffs Settlement Talks In Patent Dispute With Boston Scientific

Law360, New York (June 17, 2005, 12:00 AM EDT) -- Johnson & Johnson has rebuffed an offer to begin settlement talks by rival Boston Scientific in their patent dispute over drug-coated stents, Boston Scientific told the Boston Globe.

A J&J spokesman declined to comment on the remarks, which were attributed to a spokesman for Boston Scientific, according to the newspaper.

The report comes amid amid ongoing trials in Delaware between the companies involving patents on their competing drug-coated cardiac stents used to treat clogged arteries.

Separately, a J&J spokesman told the newspaper he couldn't comment on...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.